These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9499327)

  • 1. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.
    Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H
    Ann Intern Med; 1998 Mar; 128(6):443-50. PubMed ID: 9499327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
    Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
    N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind trial of depot corticosteroids in Behçet's syndrome.
    Mat C; Yurdakul S; Uysal S; Gogus F; Ozyazgan Y; Uysal O; Fresko I; Yazici H
    Rheumatology (Oxford); 2006 Mar; 45(3):348-52. PubMed ID: 16263779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of recurrent ulceration with low doses of thalidomide. Pilot study in 17 patients].
    de Wazières B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL
    Rev Med Interne; 1999 Jul; 20(7):567-70. PubMed ID: 10434346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study.
    Alpsoy E; Er H; Durusoy C; Yilmaz E
    Arch Dermatol; 1999 May; 135(5):529-32. PubMed ID: 10328192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome.
    Hamuryudan V; Hatemi G; Sut N; Ugurlu S; Yurdakul S; Yazici H
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S32-4. PubMed ID: 22935508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
    Melikoglu M; Fresko I; Mat C; Ozyazgan Y; Gogus F; Yurdakul S; Hamuryudan V; Yazici H
    J Rheumatol; 2005 Jan; 32(1):98-105. PubMed ID: 15630733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.
    Alpsoy E; Durusoy C; Yilmaz E; Ozgurel Y; Ermis O; Yazar S; Basaran E
    Arch Dermatol; 2002 Apr; 138(4):467-71. PubMed ID: 11939808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
    Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
    N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.
    Gardner-Medwin JM; Smith NJ; Powell RJ
    Ann Rheum Dis; 1994 Dec; 53(12):828-32. PubMed ID: 7864692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial.
    Ramirez-Amador VA; Esquivel-Pedraza L; Ponce-de-Leon S; Reyes-Teran G; Gonzalez-Guevara M; Ponce-de-Leon S; Sierra-Madero JG
    Clin Infect Dis; 1999 Apr; 28(4):892-4. PubMed ID: 10825055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind trial of colchicine in Behçet's syndrome.
    Yurdakul S; Mat C; Tüzün Y; Ozyazgan Y; Hamuryudan V; Uysal O; Senocak M; Yazici H
    Arthritis Rheum; 2001 Nov; 44(11):2686-92. PubMed ID: 11710724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
    Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
    Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of apremilast for the treatment of adult patients with oral ulcers associated with Behçet's syndrome.
    Özdede A; Hatemi G
    Expert Opin Pharmacother; 2021 Aug; 22(12):1533-1537. PubMed ID: 34218739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's disease: treatment of mucocutaneous lesions.
    Alpsoy E
    Clin Exp Rheumatol; 2005; 23(4):532-9. PubMed ID: 16095126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Hotline. Oral allicin in the treatment of Behcet's disease through attenuating oxidative stress: A pilot study in 20 patients with mucocutaneous lesions.
    Zhong J; Xian D; Xiong X; Liu J
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide in severe orogenital ulceration.
    Jenkins JS; Powell RJ; Allen BR; Littlewood SM; Maurice PD; Smith NJ
    Lancet; 1984 Dec; 2(8417-8418):1424-6. PubMed ID: 6151044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent oro-genital ulceration with low doses of thalidomide.
    De Wazières B; Gil H; Vuitton DA; Dupond JL
    Clin Exp Rheumatol; 1999; 17(3):393. PubMed ID: 10410284
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial.
    Davies UM; Palmer RG; Denman AM
    Br J Rheumatol; 1988 Aug; 27(4):300-2. PubMed ID: 3044474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
    De Luca G; Cariddi A; Campochiaro C; Vanni D; Boffini N; Tomelleri A; Cavalli G; Dagna L
    Rheumatology (Oxford); 2020 Jan; 59(1):171-175. PubMed ID: 31280296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.